Hawaii House Bill HB216

Hawaii 2025 Regular Session

• Introduced: 1/16/25
• Refer: 1/21/25

Caption

Relating To Prescription Drugs.

Impact

The bill will require health insurers to adopt minimum standards for step therapy protocols that are based on clinical practice guidelines derived from high-quality studies and expert consensus. Additionally, it mandates a clear and fair process for patients to request exceptions to these protocols when deemed appropriate by their healthcare provider. Through these provisions, HB216 intends to enhance patient access to necessary medications while ensuring that treatment decisions remain in the hands of healthcare professionals.

Summary

House Bill 216 aims to establish regulations governing the utilization of step therapy protocols within health insurance policies in Hawaii. Step therapy protocols require patients to try specific prescription drugs in a designated order before their insurance will provide coverage for the medication prescribed by their healthcare provider. The bill is motivated by concerns that these protocols, while useful for controlling healthcare costs, can also pose risks to patients, particularly those who may require immediate access to a specific medication due to varying medical conditions. Hence, the legislation seeks to ensure uniformity in the protocols, thereby protecting patients across different insurance carriers.

Contention

Notably, the bill may spark debate regarding the balance between cost containment and patient safety. Proponents argue that establishing clear protocols will promote consistency in treatment across insurers, potentially leading to better health outcomes and fewer adverse reactions caused by inappropriate medication use. Opponents may counter that such regulations could result in insurers wielding too much power over treatment plans, thereby limiting the ability of healthcare providers to offer individualized care tailored to unique patient needs.